These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 24975050)

  • 1. Effects of antihypertensive and triglyceride-lowering agents on hepatic copper concentrations in rats with fatty liver disease.
    Ackerman Z; Skarzinski G; Grozovski M; Oron-Herman M; Sela BA
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):545-51. PubMed ID: 24975050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction.
    Ackerman Z; Oron-Herman M; Grozovski M; Rosenthal T; Pappo O; Link G; Sela BA
    Hypertension; 2005 May; 45(5):1012-8. PubMed ID: 15824194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antihypertensive and triglyceride lowering agents on splenocyte apoptosis in rats with fatty liver.
    Ackerman Z; Grozovski M; Oron-Herman M; Rosenthal T; Sela BA; Amir G
    Basic Clin Pharmacol Toxicol; 2013 Jul; 113(1):37-42. PubMed ID: 23489555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liver.
    Ackerman Z; Oron-Herman M; Rosenthal T; Pappo O; Link G; Sela BA; Grozovski M
    Dig Dis Sci; 2008 Mar; 53(3):777-84. PubMed ID: 17710547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospective.
    Schmilovitz-Weiss H; Hochhauser E; Cohen M; Chepurko Y; Yitzhaki S; Grossman E; Leibowitz A; Ackerman Z; Ben-Ari Z
    Lipids Health Dis; 2013 Mar; 12():41. PubMed ID: 23531105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk reduction therapy for syndrome X: comparison of several treatments.
    Oron-Herman M; Sela BA; Rosenthal T
    Am J Hypertens; 2005 Mar; 18(3):372-8. PubMed ID: 15797656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.
    Aigner E; Strasser M; Haufe H; Sonnweber T; Hohla F; Stadlmayr A; Solioz M; Tilg H; Patsch W; Weiss G; Stickel F; Datz C
    Am J Gastroenterol; 2010 Sep; 105(9):1978-85. PubMed ID: 20407430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
    Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
    Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of soothing liver and invigorating spleen recipes on SREBP-1c mRNA and protein expression in hepatic tissues of rats with non-alcoholic fatty liver disease].
    He XM; Yang QH; Li PF; Chen Z; Feng GF; Wang WJ; Liu HT; Zhang YP; Ji GY
    Zhong Yao Cai; 2011 Jun; 34(6):931-7. PubMed ID: 22017010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic effects of rosiglitazone in rats with the metabolic syndrome.
    Ackerman Z; Oron-Herman M; Pappo O; Peleg E; Safadi R; Schmilovitz-Weiss H; Grozovski M
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):663-8. PubMed ID: 20210788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor alpha is associated with Cu2+, Zn2+-superoxide dismutase in the liver.
    Inoue I; Noji S; Awata T; Takahashi K; Nakajima T; Sonoda M; Komoda T; Katayama S
    Life Sci; 1998; 63(2):135-44. PubMed ID: 9674948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of rat liver branched-chain alpha-keto acid dehydrogenase activity by low doses of bezafibrate.
    Knapik-Czajka M
    Toxicology; 2013 Apr; 306():101-7. PubMed ID: 23485652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil.
    Polavarapu R; Spitz DR; Sim JE; Follansbee MH; Oberley LW; Rahemtulla A; Nanji AA
    Hepatology; 1998 May; 27(5):1317-23. PubMed ID: 9581686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Bezafibrate on the Survival of Random Skin Flaps in Rats.
    Lin B; Lin Y; Lin D; Cao B
    J Reconstr Microsurg; 2016 Jun; 32(5):395-401. PubMed ID: 26872027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein and antioxidant enzymes in Long-Evans Cinnamon rats treated with zinc.
    Medici V; Santon A; Sturniolo GC; D'Incà R; Giannetto S; Albergoni V; Irato P
    Arch Toxicol; 2002 Sep; 76(9):509-16. PubMed ID: 12242608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease.
    Duan XY; Zhao HP; Fan JG
    J Dig Dis; 2010 Apr; 11(2):94-100. PubMed ID: 20402835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fibrates on the glycine conjugation of benzoic acid in rats.
    Gregus Z; Fekete T; Halászi E; Gyurasics A; Klaassen CD
    Drug Metab Dispos; 1998 Nov; 26(11):1082-8. PubMed ID: 9806950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ; Li LD; Wu LM
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dietary zinc levels on the activities of enzymes, weights of organs, and the concentrations of zinc and copper in growing rats.
    Sun JY; Jing MY; Weng XY; Fu LJ; Xu ZR; Zi NT; Wang JF
    Biol Trace Elem Res; 2005 Nov; 107(2):153-65. PubMed ID: 16217140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.